|
|||||
|
|

Specialty insurance company Markel Group (NYSE:MKL) beat Wall Street’s revenue expectations in Q3 CY2025, but sales fell by 5.3% year on year to $4.37 billion. Its non-GAAP profit of $31.61 per share was 33% above analysts’ consensus estimates.
Is now the time to buy MKL? Find out in our full research report (it’s free for active Edge members).
Markel Group’s third quarter results were well received by the market, reflecting the impact of decisive restructuring and improved operating discipline across its core insurance operations. Management attributed the quarter’s performance to organizational changes such as exiting underperforming business lines, streamlining reporting structures, and investing in higher-growth international and personal lines. CEO Thomas Gayner highlighted that “every reportable segment made positive contributions,” while CFO Brian Costanzo emphasized that the new segment structure and enhanced disclosures offered greater transparency into profitability and capital allocation.
Looking forward, Markel Group’s guidance is shaped by plans to leverage its revamped segment structure, invest in technology, and pursue selective growth in profitable insurance lines. Management noted that disciplined expense management and ongoing investments—especially in personal lines and international markets—are expected to support future earnings. According to Simon Wilson, CEO of Markel Insurance, “Step by step, we're working towards achieving our full potential,” pointing to early evidence that recent actions are starting to drive better results. The company remains focused on maintaining prudent underwriting standards and capital allocation as it navigates evolving market conditions.
Management credited the quarter’s positive trajectory to specialty insurance profitability, segment realignment, and a greater emphasis on accountability within business units.
Markel’s outlook centers on maintaining underwriting discipline, scaling targeted growth areas, and continuing operational improvements to enhance long-term profitability.
Looking ahead, the StockStory team will be monitoring (1) the execution of expense reduction initiatives and technology investments in personal lines, (2) progress on underwriting discipline and portfolio rationalization in U.S. Wholesale and Specialty, and (3) growth in international and program segments, especially as new business plans are implemented for 2026. Shifts in reinsurance pricing and competitive dynamics in property and E&S markets will also be key factors to watch.
Markel Group currently trades at $1,940, up from $1,825 just before the earnings. Is the company at an inflection point that warrants a buy or sell? Find out in our full research report (it’s free for active Edge members).
When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that’s already erased most losses.
Don’t let fear keep you from great opportunities and take a look at Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| Oct-31 | |
| Oct-31 | |
| Oct-30 | |
| Oct-30 | |
| Oct-30 | |
| Oct-30 | |
| Oct-29 | |
| Oct-29 | |
| Oct-29 | |
| Oct-29 | |
| Oct-27 | |
| Oct-27 | |
| Oct-23 | |
| Oct-22 | |
| Oct-13 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite